[1] |
Reagan JL,Casti11o JJ.Why is my patient neutropenic? [J]. Hemato1 Onco1 C1in North Am,2012,26(2):253-266.
|
[2] |
何尚运,吴茅,商炜琛,等.不同浓度阿昔洛韦对家兔骨髓有核细胞和巨核细胞的影响[J].西北药学杂志,2009,24(1):33-34.
|
[3] |
朱永珙.进一步提高药品不良反应病例报告的质量[J].中国新药杂志,1999,8(1):37-38.
|
[4] |
Curtis BR.Drug-induced immune neutropenia and agranu-1ocytosis[J].Immunohemato1ogy,2014,30(2):95-101.
|
[5] |
Garbe E.Non-chemotherapydrug-inducedagranu1ocytosis [J]. Expert Opin Drug Saf,2007,6(3):323-335.
|
[6] |
万正兰,肖佩玉,梁雪梅,等.静脉滴注更昔洛韦治疗儿童传染性单核细胞增多症的不良反应观察与处理[J].临床合理用药,2013,6(9C):110-111.
|
[7] |
Chan K,Farooq R.Hyper1eucocytosis fo11owing G-CSF treatment for su1fasa1azine-induced agranu1ocytosis[J].BMJ Case Rep,2015,15(6):709.
|
[8] |
Bay1ey KB,Savitz LA,Madda1one T,et al. Eva1uation of patient care interventions and recommendations by a transitiona1 care pharmacist[J].Ther C1in Risk Manag,2007,3 (4):695-703.
|
[9] |
于国英,苏治国,孙美娟.318例药品不良反应的统计分析[J].齐鲁药事,2010,29,(2):125-126.
|
[10] |
裔照国,刘洪月,丁哲,等.1例儿童急性淋巴细胞白血病患者甲氨蝶呤致骨髓抑制伴发热临床治疗的药学监护[J].抗感染药学,2015,12(2):183-186.
|
[11] |
纪立伟,张藜莉,杨莉萍,等.丙硫氧嘧啶致粒细胞缺乏患者的药学监护[J].中国药物应用与监测,2010,7(5):302-304.
|
[12] |
刘洋,朱蓓,郭桂明,等.178例中药不良反应/事件分析[J].中国药物警戒,2010,7(1):48-51.
|
[13] |
赵辨.临床皮肤病学[M].3版.南京:江苏科学技术出版社,2001:778-779.
|
[14] |
Oxman MN.Herpes zoster pathogenesis and ce11-mediatedimmunity and immunosenescence[J].J Am Osteopath Assoc,2009,109(Supp1 2):S13-S17.
|
[15] |
陈金生,宫庆娟,黄秋兰,等.针灸对急性带状疱疹患者血液c-FLIP表达的影响[J].实用医学杂志,2013,29(15):2562-2565.
|